These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 17526941
1. Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment. Araya AV, Rojas P, Fritsch R, Rojas R, Herrera L, Rojas G, Gatica H, Silva H, Fiedler JL. Endocrine; 2006 Dec; 30(3):289-98. PubMed ID: 17526941 [Abstract] [Full Text] [Related]
2. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S, Mirtazapine-Venlafaxine Study Group. J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127 [Abstract] [Full Text] [Related]
3. Venlafaxine for treatment-resistant unipolar depression. Nierenberg AA, Feighner JP, Rudolph R, Cole JO, Sullivan J. J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023 [Abstract] [Full Text] [Related]
4. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group. Silverstone PH, Ravindran A. J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873 [Abstract] [Full Text] [Related]
5. Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial. de Montigny C, Silverstone PH, Debonnel G, Blier P, Bakish D. J Clin Psychopharmacol; 1999 Oct; 19(5):401-6. PubMed ID: 10505581 [Abstract] [Full Text] [Related]
6. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Martin SD, Martin E, Rai SS, Richardson MA, Royall R. Arch Gen Psychiatry; 2001 Jul; 58(7):641-8. PubMed ID: 11448369 [Abstract] [Full Text] [Related]
7. Relationship of cortisol levels and genetic polymorphisms to antidepressant response to placebo and fluoxetine in patients with major depressive disorder: a prospective study. Ventura-Juncá R, Symon A, López P, Fiedler JL, Rojas G, Heskia C, Lara P, Marín F, Guajardo V, Araya AV, Sasso J, Herrera L. BMC Psychiatry; 2014 Aug 03; 14():220. PubMed ID: 25086452 [Abstract] [Full Text] [Related]
8. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. Amsterdam JD, Shults J. J Clin Psychopharmacol; 2008 Apr 03; 28(2):171-81. PubMed ID: 18344727 [Abstract] [Full Text] [Related]
9. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. Rudolph RL, Fabre LF, Feighner JP, Rickels K, Entsuah R, Derivan AT. J Clin Psychiatry; 1998 Mar 03; 59(3):116-22. PubMed ID: 9541154 [Abstract] [Full Text] [Related]
11. Desmopressin and low-dose ACTH test in rheumatoid arthritis. Foppiani L, Cutolo M, Sessarego P, Sulli A, Prete C, Seriolo B, Giusti M. Eur J Endocrinol; 1998 Mar 03; 138(3):294-301. PubMed ID: 9539304 [Abstract] [Full Text] [Related]
12. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia. Ballús C, Quiros G, De Flores T, de la Torre J, Palao D, Rojo L, Gutiérrez M, Casais L, Riesgo Y. Int Clin Psychopharmacol; 2000 Jan 03; 15(1):43-8. PubMed ID: 10836286 [Abstract] [Full Text] [Related]
13. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Dierick M, Ravizza L, Realini R, Martin A. Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jan 03; 20(1):57-71. PubMed ID: 8861177 [Abstract] [Full Text] [Related]
15. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. Clerc GE, Ruimy P, Verdeau-Pallès J. Int Clin Psychopharmacol; 1994 Sep 03; 9(3):139-43. PubMed ID: 7814822 [Abstract] [Full Text] [Related]
19. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Ladd CO, Newport DJ, Ragan KA, Loughhead A, Stowe ZN. Depress Anxiety; 2005 Sep 03; 22(2):94-7. PubMed ID: 16094663 [Abstract] [Full Text] [Related]
20. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R. J Endocrinol Invest; 2004 Jun 03; 27(6):541-7. PubMed ID: 15717651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]